These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20826552)

  • 21. Effect of risperidone on QT interval and QT dispersion in the elderly.
    Yerrabolu M; Prabhudesai S; Tawam M; Winter L; Kamalesh M
    Heart Dis; 2000; 2(1):10-2. PubMed ID: 11728238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
    Motlová L; Spaniel F; Höschl C; Balon R
    Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.
    Jensen KG; Juul K; Fink-Jensen A; Correll CU; Pagsberg AK
    J Am Acad Child Adolesc Psychiatry; 2015 Jan; 54(1):25-36. PubMed ID: 25524787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study.
    Hough DW; Natarajan J; Vandebosch A; Rossenu S; Kramer M; Eerdekens M
    Int Clin Psychopharmacol; 2011 Jan; 26(1):25-34. PubMed ID: 20881844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using oral ziprasidone effectively: the food effect and dose-response.
    Citrome L
    Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.
    Wilton LV; Heeley EL; Pickering RM; Shakir SA
    J Psychopharmacol; 2001 Jun; 15(2):120-6. PubMed ID: 11448085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
    Spellmann I; Reinhard MA; Veverka D; Zill P; Obermeier M; Dehning S; Schennach R; Müller N; Möller HJ; Riedel M; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):383-390. PubMed ID: 29429138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of antipsychotics and QTc prolongation: a pilot study.
    Høimark L; Uhrskov Sørensen L; Vukelic Andersen L
    Nord J Psychiatry; 2020; 74(5):374-379. PubMed ID: 32105154
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone and corrected QT-interval prolongation in surface electrocardiogram.
    Ranjbar F; Akbarzadeh F; Ahmadi NM; Abbasnejhad M
    Pak J Biol Sci; 2012 May; 15(10):496-500. PubMed ID: 24187905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 33. Sertindole in schizophrenia: efficacy and safety issues.
    Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
    Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study.
    Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1222-32. PubMed ID: 23857878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
    Lin CH; Chen MC; Wang SY; Lin CY
    J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?
    Aichhorn W; Whitworth AB; Weiss EM; Marksteiner J
    Drug Saf; 2006; 29(7):587-98. PubMed ID: 16808551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Yang FD; Wang XQ; Liu XP; Zhao KX; Fu WH; Hao XR; Zhang XL; Huang GS; Qu SC; Bai JS; Huang XF; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2011 Jul; 216(1):9-16. PubMed ID: 21301815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic drugs and QT prolongation.
    Stöllberger C; Huber JO; Finsterer J
    Int Clin Psychopharmacol; 2005 Sep; 20(5):243-51. PubMed ID: 16096514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amisulpride overdose: suggested management of prolonged QTc.
    Stevenson RJ
    Emerg Med J; 2010 Jul; 27(7):565. PubMed ID: 20584965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval.
    Schmidt A; Fischer P; Wally B; Scharfetter J
    Neuropsychiatr; 2017 Dec; 31(4):172-175. PubMed ID: 28791627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.